Viking Therapeutics got the market's attention with robust phase 2 results for VK2735, a potential weight loss therapy.

MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...

Several ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory ...

Co., Inc. (NYSE: MRK) has initiated a pivotal Phase 3 clinical trial, waveLINE-010, to evaluate the efficacy of its investigational drug zilovertamab vedotin in treating patients with previously ...

Paradigm Biopharmaceuticals has selected Advanced Clinical as the preferred clinical research organisation for the phase III ...

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the ...

In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve ...

Kura Oncology and Kyowa Kirin reported positive Phase 2 results for ziftomenib in AML and plan Phase 3 trials, with an NDA ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

Relmada, which has turned to strategic options after scrapping two phase 3 trials in major depressive disorder (MDD), is ...

This study builds on the promising outcomes of the QUILT 3.055 Phase II trial, which indicated that the combination of a CPI ...